Works (1)
2021 journal article
Fibrin‐specific poly(N‐isopropylacrylamide) nanogels for targeted delivery of tissue‐type plasminogen activator to treat thrombotic complications are well tolerated in vivo
Bioengineering & Translational Medicine, 7(2).